EA
ABBV icon

Edge Advisors’s AbbVie ABBV Stock Holding History

Edge Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$2.83M Sell
30,497
-1,210
-4% -$118K 0.25% 98
2018
Q1 		$3M Sell
31,707
-3,234
-9% -$355K 0.28% 88
2017
Q4 		$3.38M Sell
34,941
-461
-1% -$43.4K 0.33% 78
2017
Q3 		$3.15M Sell
35,402
-15,977
-31% -$1.22M 0.34% 73
2017
Q2 		$3.72M Buy
51,379
+756
+1% +$50.8K 0.42% 63
2017
Q1 		$3.3M Buy
50,623
+3,379
+7% +$212K 0.4% 60
2016
Q4 		$2.96M Buy
+47,244
New +$2.88M 0.38% 65

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Edge Advisors's ABBV Position: Q2 2018 in Review

Edge Advisors reduced its AbbVie (ABBV) stake by 3.8% in Q2 2018, selling an estimated $118K and leaving 30,497 shares worth $2.83M. The position accounts for 0.25% of the portfolio, ranked #98.

Edge Advisors first reported a position in ABBV in Q4 2016 and has held it in 7 quarters since. The position peaked at $3.72M in Q2 2017. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • Edge Advisors held 30,497 shares of AbbVie worth $2.83M as of Q2 2018.
  • Edge Advisors sold 1,210 AbbVie shares in Q2 2018, an estimated $118K.
  • AbbVie made up 0.25% of Edge Advisors's portfolio in Q2 2018, its #98 holding.
  • Edge Advisors first reported a position in AbbVie in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's AbbVie position peaked at $3.72M in Q2 2017.
  • 1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.